simvastatin has been researched along with Venous Thrombosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Lei, B; Niu, L; Zhang, F; Zhang, H; Zhang, M | 1 |
| Feng, Y; Niu, L; Zhang, F; Zhang, M | 1 |
| Aberg, M; Johnell, M; Siegbahn, A; Wickström, M; Widunder, A | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
| Andrus, MR | 1 |
| Doggen, CJ; Heckbert, SR; Lemaitre, RN; Psaty, BM; Smith, NL | 1 |
| Platts, J | 1 |
1 review(s) available for simvastatin and Venous Thrombosis
| Article | Year |
|---|---|
Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atorvastatin; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; International Normalized Ratio; Male; Patient Compliance; Pyrroles; Simvastatin; Venous Thrombosis; Warfarin | 2004 |
6 other study(ies) available for simvastatin and Venous Thrombosis
| Article | Year |
|---|---|
Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi.
Topics: Animals; Anti-Inflammatory Agents; Cell Movement; Cytokines; Inflammation; Lipids; Male; Rabbits; Simvastatin; Venous Thrombosis | 2017 |
Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Gene Expression Regulation; Heparin, Low-Molecular-Weight; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; P-Selectin; Plasminogen Activator Inhibitor 1; Rabbits; Simvastatin; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vena Cava, Superior; Venous Thrombosis | 2016 |
Simvastatin reduces the production of prothrombotic prostasomes in human prostate cancer cells.
Topics: Anticholesteremic Agents; Apoptosis; Cell Line, Tumor; Culture Media, Conditioned; Dose-Response Relationship, Drug; Down-Regulation; Flow Cytometry; Humans; Male; Particle Size; Prostatic Neoplasms; Simvastatin; Thromboplastin; Venous Thrombosis | 2008 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Case-Control Studies; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Postmenopause; Pravastatin; Risk; Simvastatin; Venous Thrombosis | 2004 |
Therapy and clinical trials.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Neoplasms; Risk Assessment; Simvastatin; Venous Thrombosis | 2002 |